Minor-clone TP53 mutations in CLL patients entering first-line treatment: clonal evolution and clinical impact
The result's identifiers
Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F65269705%3A_____%2F20%3A00073113" target="_blank" >RIV/65269705:_____/20:00073113 - isvavai.cz</a>
Alternative codes found
RIV/00216224:14740/20:00114040
Result on the web
<a href="https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1732667" target="_blank" >https://www.tandfonline.com/doi/abs/10.1080/10428194.2020.1732667</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1080/10428194.2020.1732667" target="_blank" >10.1080/10428194.2020.1732667</a>
Alternative languages
Result language
angličtina
Original language name
Minor-clone TP53 mutations in CLL patients entering first-line treatment: clonal evolution and clinical impact
Original language description
Aims .To assess the risk of clonal expansion of minor-clone TP53 mutations . To evaluate the clinical impact of TP53 mutations with different variant allele frequencies VAFs on event-free survival (EFS) after treatment as well as on overall survival (OS).
Czech name
—
Czech description
—
Classification
Type
O - Miscellaneous
CEP classification
—
OECD FORD branch
30204 - Oncology
Result continuities
Project
Result was created during the realization of more than one project. More information in the Projects tab.
Continuities
P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)
Others
Publication year
2020
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů